The pathobiology of severe asthma, poorly response to glucocorticoids, remains poorly understood. Recent evidence suggests that a nonspecific and chronic wound repair process exists in severe asthmatic airways highlighted by increases in the """"""""anti-inflammatory"""""""" and profibrotic cytokine, transforming growth factor-beta (TGF-beta). An associated up-regulation of a specific allergic response also is present, hallmarked by increases in the TH2 cytokine, interleukin (IL)-13, and the eicosanoid, 15 hydroxyeicosatetraenoic (HETE). Little is known regarding the interactions between these nonspecific and specific """"""""inflammatory modulating"""""""" pathways. This proposal will examine the regulation and interrelationships of these two pathways, and how dysregulation in these pathways could promote fibrotic responses in severe asthma. To accomplish this, specific aim number 1 will evaluate the quantitative and qualitative differences in the enzyme 15 lipoxygenase (LO) (protein and mRNA), its product, 15S HETE. and TGF-beta1 (protein and mRNA) in the airways of severe asthmatics, compared to control groups. This will include an evaluation of the differences in the cell types and patterns of expression of these mediators utilizing colocalization studies for protein/mRNA in tissue and specific isolated cell culture systems.
Specific aim number 2 will focus on the direct and indirect regulatory effects of IL-13 and angiotensin II (potential stimulatory factors) on 15S HETE/15L0 and TGF-beta1. IL-13 and angiotensin II will be quantified in the tissue. Then, the effects of these mediators on TGF-beta1 and 15S HETE in fell systems will be evaluated.
Specific aim number 3 will determine whether 15S HETE, the product of 15 LO, influences signaling in angiotensin II/TGF-beta1 pathways through incorporation into membrane phospholipids. Additional studies will determine whether membrane incorporation of 15S HETE decreases activation of protein kinase C pathways through increased oxidation of diacylglycerol. In all the specific aims, comparison will be made between the normal responses and the abnormal responses occurring in asthma, particularly severe asthma. It is hoped than a better understanding of the interactions of these two """"""""anti-inflammatory"""""""" pathways (one nonspecific, the other specific (allergic)) will improve not only the understanding of responses to injury in asthma, but also in many other diseases associated with an injury/repair/fibrosis cycle.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI040600-06
Application #
6510523
Study Section
Lung Biology and Pathology Study Section (LBPA)
Program Officer
Adams, Ken
Project Start
1996-12-01
Project End
2005-03-31
Budget Start
2002-04-01
Budget End
2003-03-31
Support Year
6
Fiscal Year
2002
Total Cost
$269,150
Indirect Cost
Name
National Jewish Health
Department
Type
DUNS #
City
Denver
State
CO
Country
United States
Zip Code
80206
Wenzel, Sally E; Tyurina, Yulia Y; Zhao, Jinming et al. (2017) PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals. Cell 171:628-641.e26
Zhao, Jinming; Minami, Yoshinori; Etling, Emily et al. (2017) Preferential Generation of 15-HETE-PE Induced by IL-13 Regulates Goblet Cell Differentiation in Human Airway Epithelial Cells. Am J Respir Cell Mol Biol 57:692-701
Wenzel, Sally E (2016) Emergence of Biomolecular Pathways to Define Novel Asthma Phenotypes. Type-2 Immunity and Beyond. Am J Respir Cell Mol Biol 55:1-4
Ray, Anuradha; Raundhal, Mahesh; Oriss, Timothy B et al. (2016) Current concepts of severe asthma. J Clin Invest 126:2394-403
Albano, Giusy D; Zhao, Jinming; Etling, Emily B et al. (2015) IL-13 desensitizes ?2-adrenergic receptors in human airway epithelial cells through a 15-lipoxygenase/G protein receptor kinase 2 mechanism. J Allergy Clin Immunol 135:1144-53.e1-9
Xie, Min; Mustovich, Anthony T; Jiang, Yi et al. (2015) IL-27 and type 2 immunity in asthmatic patients: association with severity, CXCL9, and signal transducer and activator of transcription signaling. J Allergy Clin Immunol 135:386-94
Traister, Russell S; Uvalle, Crystal E; Hawkins, Gregory A et al. (2015) Phenotypic and genotypic association of epithelial IL1RL1 to human TH2-like asthma. J Allergy Clin Immunol 135:92-9
Watanabe, Tetsuya; Fajt, Merritt L; Trudeau, John B et al. (2015) Brain-Derived Neurotrophic Factor Expression in Asthma. Association with Severity and Type 2 Inflammatory Processes. Am J Respir Cell Mol Biol 53:844-52
Ray, Anuradha; Oriss, Timothy B; Wenzel, Sally E (2015) Emerging molecular phenotypes of asthma. Am J Physiol Lung Cell Mol Physiol 308:L130-40
Trejo Bittar, Humberto E; Yousem, Samuel A; Wenzel, Sally E (2015) Pathobiology of severe asthma. Annu Rev Pathol 10:511-45

Showing the most recent 10 out of 38 publications